STAGE IIC PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIC PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIC PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIC PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Safe prostate cancer treatment? new study compares two drugs
Disease control Recruiting nowThis study compares two hormone therapies, Orgovyx and Eligard, used alongside radiation for prostate cancer. The goal is to see which one is less harmful to the heart. About 70 men with intermediate-risk prostate cancer will take one of the drugs for 6 months and undergo heart t…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:35 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has returned or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:30 UTC
-
Could a targeted drug boost prostate cancer treatment?
Disease control Recruiting nowThis study is for men with high-risk prostate cancer that hasn't spread far. It tests whether adding the drug niraparib to standard hormone therapy after radiation can better control the cancer. About 200 participants will receive either hormone therapy alone or with niraparib. T…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Hormone boost before scan may reveal hidden prostate cancer
Diagnosis Recruiting nowThis study tests whether taking a hormone-blocking drug (relugolix) for a few days before a PSMA PET/CT scan can make prostate cancer cells more visible. The goal is to improve detection of cancer that has spread to lymph nodes in men with high-risk prostate cancer. About 30 part…
Matched conditions: STAGE IIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 19, 2026 12:00 UTC